Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma
- 1 August 2006
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 55 (2) , 324-327
- https://doi.org/10.1016/j.jaad.2006.04.004
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Imiquimod Treatment of Superficial and Nodular Basal Cell Carcinoma: 12-Week Open-Label TrialDermatologic Surgery, 2006
- Dosing With 5% Imiquimod Cream 3 Times per Week for the Treatment of Actinic KeratosisArchives of Dermatology, 2005
- Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studiesJournal of the American Academy of Dermatology, 2004
- Role of Imiquimod in Skin Cancer TreatmentAmerican Journal of Clinical Dermatology, 2004
- Treatment of Bowen's disease using a cycle regimen of imiquimod 5% creamClinical and Experimental Dermatology, 2003
- Treatment of large facial Bowen's disease: case reportClinical and Experimental Dermatology, 2003
- Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry.British Journal of Dermatology, 2002
- Treatment of Bowen's disease of the penis with imiquimodJournal of the American Academy of Dermatology, 2002
- Topical imiquimod 5% cream in the treatment of Bowen's disease of the penisJournal of the American Academy of Dermatology, 2002
- Imiquimod 5% cream in the treatment of Bowen's diseaseJournal of the American Academy of Dermatology, 2001